Govt ammonia restriction sparks pharma raw material fears and possible medicine shortages

Pharma says a fertiliser-only cap could choke API supplies

India’s drugmakers are warning that a government directive restricting surplus ammonia supply to fertiliser firms could trigger a raw material crunch for pharmaceuticals. Since ammonia is a key input for API production, limited alternative sourcing may disrupt manufacturing, raise the risk of medicine shortages, and hit export commitments.